|
Women with diabetes can take low-dose combined oral contraception. Low-dose COCs - contain less than 35 mcg of estrogen component. They are: monophasic "Marvelon", "Femoden", "regulon", "Janine", "Yasmin", "Chloe"; Three-phase: "The three-regolith", "Three-merci", "Trikvilar", "Milvane." Microdosage COC - contain 20 micrograms or less of estrogen component. These preparations include monophasic "Lindinet" "Logest" "Novinet" "Mersilon", "Merrill" "Jacks," and others. For women with diabetes, a new step in the development of contraception became COC's that contain estradiol valerate and dienogest, dynamic dosing regimen ("Klayra"). All combined oral contraceptives increase the levels of triglycerides in the blood. But this is a negative risk factor only for those women who before taking this pills had hypertriglyceridemia. If a woman has a moderate dyslipidemia (abnormal lipid metabolism), this combined hormonal contraception are relatively safe. But at the time of their admission the patient must do regular blood tests for triglycerides. Hormonal vag*inal ring NuvaRing The vag*inal type of administration, is a steroid hormone for contraception - in many ways is better than COC pills. The concentration of hormones in blood are maintained stable. The active ingredients are not subjected to pass through the liver, as ingested pills. Therefore, while using vaginal contraceptive hormones, their daily dose can be reduced. NuvaRing hormonal ring is a contraceptive device in the form of a transparent ring, its diameter is near 54 mm and a thickness of 4 mm in cross-section. Every day it allocates 15 mcg of ethinyl estradiol and 120 mcg etonogestrel, an active metabolite of desogestrel. It must be worn for 21 days, then take a break for 7 days. This method of contraception has minimal effect on the metabolism of carbohydrates and fats, is about the same as microdosed combined oral contraceptives. Hormonal vag*inal ring NuvaRing is especially indicated for use in women who have diabetes combined with obesity, higher levels of triglycerides in the blood or liver dysfunction. According to studies, indicators of vag*inal health this drug doesn't change. It will be useful to tell that women with obesity and / or raised sugar in blood due to diabetes are especially prone to vulvovaginal candidiasis. This means that if you have a yeast infection, most likely, it is not a side effect of the use of vaginal contraceptive NuvaRing, and have other reasons. Intrauterine contraceptive devices Intrauterine contraceptive devices use up to 20% of the women with diabetes. Because this type of contraception is reliable and at the same time reversible protects against pregnancy. To women it is very convenient, you don't need to monitor it carefully every day, as while taking birth control pills. Additional benefits of intrauterine contraceptive device in patients with diabetes: they don't impair the performance of carbohydrate and fat, they don't increase the likelihood of blood clots and blockage of blood vessels by them. The disadvantages of this type of contraception: in women more likely are developed disorders of the menstrual cycle (giperpolimenoreya and dysmenorrhea), and is increased risk of ectopic pregnancy, can occur more often inflammatory diseases of the pelvic organs, especially if the diabetes blood sugar is consistently high. For women which has not yet given birth, the use of intrauterine contraceptive devices is not recommended. Women in childbearing age can pick up a suitable option, but it is better to choose a method of contraception together with your physician. At the same time, be prepared that you have to try a few different ways of contraception until you will decide which one suits you best.
Related Articles -
oral contraception, combined contraception, hormonal contraception, combined oral contraceptions, birth control pills, spermicides, prevent pregnancy,
|
